Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implications of EGFR inhibition in ovarian cancer cell proliferation.

Gynecologic oncology - 1 Jun 2008

Bull Phelps Shawna L, Schorge John O, Peyton Michael J, Shigematsu Hisayuki, Xiang Li-Lin, Miller David S, Lea Jayanthi S

Abstract excerpt

OBJECTIVES: Epidermal Growth Factor Receptor (EGFR) is one of the four members of the Human Epidermal Receptor (HER) family and is over-expressed in multiple malignancies. EGFR over-expression in ovarian cancer has been associated with poor prognosis. Targeted inhibition of EGFR via its tyrosine kinase domain is a successful treatment in lung cancer. Our objective was to correlate EGFR over-expression and growth...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Growth Processes

Share to Cetuximab

Share to Gefitinib

Share to Ovarian Neoplasms

Share to Protein Kinase Inhibitors

Share to Quinazolines

Source

Identifiers

PMID: 18423824
DOI: 10.1016/j.ygyno.2008.02.030

Genes

EGFR
EGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implications of EGFR inhibition in ovarian cancer cell proliferation.PMID 18423824Read ↗

The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer.Semantic proximity Read ↗

Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancerSemantic proximity Read ↗

Cell proliferation of human ovarian cancer is regulated by the opioid growth factor-opioid growth factor receptor axisSemantic proximity Read ↗

Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signalingSemantic proximity Read ↗

Targeting EGFR and PI3K pathways in ovarian cancerSemantic proximity Read ↗

Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.Semantic proximity Read ↗

Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target.Semantic proximity Read ↗

Lack of direct association between EGFR mutations and ER beta expression in lung cancer.Semantic proximity Read ↗

Expression of the E2F Family of Transcription Factors and Its Clinical Relevance in Ovarian CancerSemantic proximity Read ↗

Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivationSemantic proximity Read ↗

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.Semantic proximity Read ↗

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.